PAPILLOMAVIRUS INFECTION
Clinical trials for PAPILLOMAVIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new PAPILLOMAVIRUS INFECTION trials appear
Sign up with your email to follow new studies for PAPILLOMAVIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new immune drug outsmart Hard-to-Treat tumors?
Disease control Recruiting nowThis trial tests an experimental drug called STAR0602, which is designed to help the immune system attack cancer cells. It is being studied in people with advanced solid tumors that have not responded to standard treatments. The drug is given alone or combined with chemotherapy, …
Matched conditions: PAPILLOMAVIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Marengo Therapeutics, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Gene therapy retreatment aims to cut surgeries for rare throat tumor condition
Disease control Recruiting nowThis study tests a gene therapy called Zopapogene imadenovec (Zopa) in 30 adults with recurrent respiratory papillomatosis (RRP), a condition causing non-cancerous throat tumors that often require repeated surgeries. One group will check how the virus used in the therapy leaves t…
Matched conditions: PAPILLOMAVIRUS INFECTION
Phase: PHASE4 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
HPV vaccine lesson in one school may raise consent rates
Knowledge-focused Recruiting nowThis study examines whether an HPV education program called e-Bug, used in one middle school in France, is linked to higher parental consent and vaccination rates. Researchers compared anonymized vaccination data from that school with regional averages. No students were directly …
Matched conditions: PAPILLOMAVIRUS INFECTION
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC